The Nanjing R&D laboratory of OnenessPoint, which was built and put into operation, is committed to building a leading R&D laboratory platform in the field of synthetic biology in China, and has purchased many advanced equipment and instruments from home and abroad, including fermenters, constant te Read More

October 20, 2022, OnenessPoint's parent company, YaoSynBio Technologies (Nanjing) Co, (hereinafter referred to as " YaoSynBio ") has officially completed and put into operation its 1500 square meters synthetic biology laboratory in Jiangbei New District, Nanjing. The completion and operation of YaoS Read More

Build a non-model biological automation transformation platformAndy Zhuang believes that although there is a short-term overheating trend in the development of synthetic biology, in the long run it is still in a 30-year upward phase of the general trend. Entering companies should primarily build a l Read More

According to CB Insights, synthetic biology startups will raise $18 billion globally in 2021, which is nearly as much as all the investments received in the previous 12 years (2009-2020) in one year, and this year, the investment wave could reach a new high.So far in 2022, more than 20 domestic synt Read More

Currently, synthetic biology leaps to new development and has a wide market space. Under the development of synthetic biology, the chemical industry is expected to get rid of the import dependence situation with synthetic biology technology.Meanwhile, green biology manufacturing is one of the key de Read More

On May 6th, the landing ceremony of "Synthetic Biology Automated Strain Transformation Platform" was held in Jiangbei New District Biomedical Valley. This project is a milestone in the development of high-throughput strains, especially in the development of synthetic strains of terpenoids and fatty Read More